MicroBiome Therapeutics

Share on: 
Business Area(s): 

MicroBiome Therapeutics™ (MBT) is developing novel non-perscription therapies that improve health status by interacting with the human microbiome in specific ways.  We are a leader in the development of evidence-based microbiome modulators–products designed to alter bacterial populations and their environment in the gastrointestinal (GI) tract to help prevent or treat health conditions. We are currently focused on prediabetes and newly diagnosed type 2 diabetes.

New Orleans LA
United States